Skip to main content
QuestionsResearchTagsGuidelinesLeaderboard
tachyDx Research Portal

Research tagged [surgery]

Every paper is generated from a real clinical discussion on tachyDx, peer-reviewed by verified physicians, and published with a unique TDX identifier. All contributors are credited.

DOIs registered viaCrossref
Published26Under ReviewFlagged
Clear filters

3 papers

TDX-2026-00026

Low-Titer Group O Whole Blood Resuscitation in Civilian Massive Hemorrhage: An Evidence Synthesis and Implementation Review

Massive hemorrhage remains a leading cause of preventable death in trauma. Traditional resuscitation protocols, often based on 1:1:1 component therapy (packed red blood cells, fresh frozen plasma, platelets), aim to mitigate trauma-induced coagulopathy. However, logistical challenges and delays associated with component preparation have prompted exploration of alternative strategies. Low-titer group O whole blood (LTOWB) has emerged as a promising option, offering a physiologically balanced resuscitation product. This paper synthesizes expert clinical perspectives and recent trial data regarding the transition to LTOWB in civilian trauma centers. Findings indicate that a hybrid approach, utilizing LTOWB for initial resuscitation units, can accelerate balanced resuscitation and improve hemostatic parameters. While logistical hurdles such as shelf life and inventory management persist, strategies for mitigation have been developed. Furthermore, LTOWB significantly reduces administrative errors and simplifies resuscitation protocols in high-stress environments. The role of dried plasma as a pre-hospital adjunct, particularly in settings with prolonged transport times or challenging cold chain logistics, is also discussed. The collective evidence suggests that LTOWB represents a valuable advancement in massive hemorrhage resuscitation, warranting careful consideration for integration into institutional protocols.

A physician-only Q&A platform where verified medical doctors share clinical knowledge, debate evidence, and build the knowledge base the world needs.

Powered by

Platform

  • Questions
  • Research
  • Tags
  • Guidelines
  • Leaderboard
  • Report a Bug

Ecosystem

  • Teams
  • Sponsors
  • Hiring
  • Publishing
  • CME
  • Data

Company

  • About
  • Support
  • Privacy Policy
  • Terms of Service
  • Contact

© 2026 Aethryva Deeptech Pvt Ltd. All rights reserved.

Crossref Member
2 contributors 82 votes 9 Apr 2026

TDX-2026-00025

Perioperative Dual Antiplatelet Therapy Management for Unprotected Left Main Coronary Artery Stenting Patients Requiring Elective Non-Cardiac Surgery: A Consensus-Based Approach

Patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES) require dual antiplatelet therapy (DAPT) to prevent stent thrombosis, a potentially catastrophic event. For unprotected left main coronary artery (ULMCA) PCI, guideline-recommended DAPT duration is typically 12 months. However, the need for elective non-cardiac surgery within this period presents a significant clinical dilemma, balancing the high risk of stent thrombosis if DAPT is prematurely discontinued against the increased bleeding risk during surgery if antiplatelets are continued. This paper synthesizes expert opinions from a clinical Q&A platform regarding the optimal management of a 71-year-old male who underwent ULMCA PCI with a Synergy everolimus-eluting stent 5 months prior and now requires an elective right hemicolectomy for well-differentiated adenocarcinoma. The consensus emphasizes delaying surgery to at least 9 months post-PCI if oncologically feasible. If surgery cannot be delayed, a bridging strategy with intravenous cangrelor is recommended, alongside aspirin continuation, meticulous perioperative monitoring, and a multidisciplinary team approach involving cardiology, oncology, surgery, and anesthesiology. This expert consensus highlights the critical need for individualized risk assessment, shared decision-making, and adherence to established protocols while acknowledging the limitations of current evidence specifically for ULMCA PCI in this high-risk scenario.

3 contributors 118 votes 9 Apr 2026

TDX-2026-00021

Transjugular Intrahepatic Portosystemic Shunt (TIPS) versus Serial Large-Volume Paracentesis for Refractory Ascites in Cirrhosis with MELD 18: A Clinical Decision Analysis and Evidence Synthesis

Patients with advanced cirrhosis frequently develop refractory ascites, a significant cause of morbidity and mortality. Management options include serial large-volume paracentesis (LVP) and transjugular intrahepatic portosystemic shunt (TIPS). This paper synthesizes expert clinical perspectives and current literature to address the optimal management strategy for a 56-year-old male with alcohol-related cirrhosis, Child-Pugh C, and a MELD score of 18, experiencing refractory ascites requiring frequent LVP. The discussion focuses on the efficacy, safety, and transplant implications of TIPS compared to LVP. Evidence from meta-analyses and real-world cohorts suggests TIPS offers superior ascites control and potential transplant-free survival benefits, particularly in carefully selected patients. While a MELD score of 18 approaches a critical threshold for increased post-TIPS mortality, factors such as sustained abstinence, absence of current hepatic encephalopathy, and technical feasibility favor TIPS in this specific case. The interaction of TIPS with liver transplant candidacy and surgical complexity is also explored, indicating minimal adverse impact. This analysis underscores the importance of individualized risk-benefit assessment in managing refractory ascites at the MELD 18 threshold, advocating for TIPS with a tailored protocol to mitigate risks and improve patient outcomes while awaiting liver transplantation.

2 contributors 62 votes 9 Apr 2026
Page 1 of 2Next →

Topics

Allpharmacology8critical-care7cardiology6emergency-medicine6oncology5pulmonology5nephrology4neurology4gastroenterology3immunology3hematology3surgery3infectious-disease3radiology2endocrinology2anesthesiology2hepatology2pediatrics2rheumatology2evidence-based-medicine1orthopedics1trauma1neonatology1psychiatry1internal-medicine1